Drugs and the Neuroscience of Behavior

An Introduction to Psychopharmacology

• Coverage of new major topics includes CRISPR genetic technology, effects of the microbiome on the nervous system, and behavioral mechanisms of drug action.
• A new chapter on depressants introduces depressant substances, which includes coverage of barbiturates, benzodiazepines, Z-drugs, GHB and inhalants. Content includes characteristics of depressant drugs, the role of GABA for effects of many depressants, and GABAA receptor subtypes that GHB binds to.

KEY FEATURES:

• Chapter-opening outlines and learning objectives prepare students for forthcoming material and identify what they should be able to accomplish upon completion of the reading.
• From Actions to Effects sections provide focus on a topic drawing from multiple chapter concepts to show how the actions of a drug produce its effects.
• Stop & Check questions concluding each section in every chapter allow students to assess their own understanding of main points covered in the previous section.
• Review! callouts serve as important reminders of information covered in previous chapters to help students make connections and understand new concepts.
• Drug Profiles provide basic information about a key compound and include a drug’s generic name, trade name and/or street name, and a description of its pharmacological actions.
• Research Techniques and Methods boxes cover a research technique or method used in psychopharmacology research and serve as an easy reference when students come across research findings derived from each technique.
• Chapter-ending summaries and key terms allow readers to review and reinforce the material.